BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21546779)

  • 21. Charcot-Marie-Tooth disease in northern Finland.
    Rantala H; Tolonen U; Myllylä V
    Ann Clin Res; 1986; 18(3):154-9. PubMed ID: 3740791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth disease.
    Buteică E; Roşulescu E; Stănoiu B; Burada F; Stănoiu C; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(1):115-9. PubMed ID: 18273515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamometry of intrinsic hand muscles in patients with Charcot-Marie-Tooth disease.
    Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    Neurology; 2006 Dec; 67(11):2022-7. PubMed ID: 17159111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
    Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
    Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.
    Haberlová J; Seeman P
    Pediatr Neurol; 2010 Dec; 43(6):407-10. PubMed ID: 21093731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charcot-Marie-Tooth disease in Molise, a central-southern region of Italy: an epidemiological study.
    Morocutti C; Colazza GB; Soldati G; D'Alessio C; Damiano M; Casali C; Pierelli F
    Neuroepidemiology; 2002; 21(5):241-5. PubMed ID: 12207152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.
    Sevilla T; Jaijo T; Nauffal D; Collado D; Chumillas MJ; Vilchez JJ; Muelas N; Bataller L; Domenech R; Espinós C; Palau F
    Brain; 2008 Nov; 131(Pt 11):3051-61. PubMed ID: 18812441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Strategies for clinical and molecular diagnosis of Charcot-Marie-Tooth 1A among Mexican patients].
    Hernández-Zamora E; Arenas-Sordo Mde L; Escobar-Cedillo RE; González-Huerta NC; Leyva-García N; Maldonado-Rodríguez R
    Gac Med Mex; 2007; 143(5):383-9. PubMed ID: 18246932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between weakness and axonal loss in patients with CMT1A.
    Krajewski K; Turansky C; Lewis R; Garbern J; Hinderer S; Kamholz J; Shy ME
    Ann N Y Acad Sci; 1999 Sep; 883():490-2. PubMed ID: 10586281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topographic distribution of multiple sclerosis in the Belgrade municipalities].
    Pekmezović T; Jarebinski M; Drulović J; Stojsavljević N; Peković N; Lević Z
    Srp Arh Celok Lek; 2001; 129(1-2):5-8. PubMed ID: 11534282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease.
    Hoff JM; Gilhus NE; Daltveit AK
    Neurology; 2005 Feb; 64(3):459-62. PubMed ID: 15699375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis on the prevalence of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies.
    Ma M; Li Y; Dai S; Chu M; Sun L; Liu L; Zhou JC
    J Neurol; 2023 May; 270(5):2468-2482. PubMed ID: 36631678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utilization of occupational therapy services for persons with Charcot-Marie-Tooth disease.
    Matyjasik-Liggett M; Wittman P
    Occup Ther Health Care; 2013 Jul; 27(3):228-37. PubMed ID: 23855609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease.
    Niu HX; Wang RH; Xu HL; Song B; Yang J; Shi CH; Li YS; Zhang BQ; Wang SP; Yong Q; Wang YY; Xu YM
    Chin Med J (Engl); 2017 Aug; 130(15):1773-1778. PubMed ID: 28748848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Charcot-Marie-Tooth disease Patient Registry in Japan].
    Okabe Y; Tsuji Y; Noto YI; Kitaoji T; Kojima Y; Kitani-Morii F; Mizuno T; Nakagawa M
    Rinsho Shinkeigaku; 2023 Jun; 63(6):350-358. PubMed ID: 37197973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Self-Selected Exercise on Strength in Charcot-Marie-Tooth Disease Subtypes.
    Djordjevic D; Fell S; Baker S
    Can J Neurol Sci; 2017 Sep; 44(5):572-576. PubMed ID: 28669366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and orthopedic management of foot and ankle deformities in Charcot-Marie-Tooth disease.
    Laurá M; Singh D; Ramdharry G; Morrow J; Skorupinska M; Pareyson D; Burns J; Lewis RA; Scherer SS; Herrmann DN; Cullen N; Bradish C; Gaiani L; Martinelli N; Gibbons P; Pfeffer G; Phisitkul P; Wapner K; Sanders J; Flemister S; Shy ME; Reilly MM;
    Muscle Nerve; 2018 Feb; 57(2):255-259. PubMed ID: 28632967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study.
    Padua L; Aprile I; Cavallaro T; Commodari I; La Torre G; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A;
    Neurol Sci; 2006 Dec; 27(6):417-23. PubMed ID: 17205227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.